Congxin Liang

nLIGHT (United States)United States

Physics and Astronomy · Physical Sciences

23h-index2.6kcitations32works1.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?


Research Topics

Advanced Chemical Physics Studies(6), PI3K/AKT/mTOR signaling in cancer(4), Spectroscopy and Quantum Chemical Studies(4), Angiogenesis and VEGF in Cancer(3), Crystallography and molecular interactions(3)

Publications32 total

Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion.
PubMed·2003· 114 cited
A novel cdk2-selective inhibitor, SU9516, induces apoptosis in colon carcinoma cells.
PubMed·2001· 146 cited
Indolinone tyrosine kinase inhibitors block Kit activation and growth of small cell lung cancer cells.
PubMed·2001· 98 cited
SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.
PubMed·2000· 497 cited
Berichte der Bunsengesellschaft für physikalische Chemie·1997· 2 cited
Journal of the American Chemical Society·1994· 28 cited
The Journal of Physical Chemistry·1993· 170 cited
page 1 of 2Next →

Frequent Co-authors

Gerald McMahon(8), Henry F. Schaefer(7), Li Sun(6), Cho Tang(5), Kenneth E. Lipson(5), Leland C. Allen(5), Audie Rice(3), Carl S. Ewig(3), Terry R. Stouch(3), A. T. Hagler(3), James Cheng‐Chung Wei(3), Laura K. Shawver(2), Robert A. Blake(2), Flora Tang(2), Marshall D. Newton(2), Anthony R. Howlett(2), David Kiewlich(2), Stefan Vasile(2), Jean Cui(2), Yong Zhou(2)